Genetics of Cerebral Hemorrhage with Anticoagulation (GOCHA)
Biomarkers (1)
- Platelet - Platelet lab value at admission (cases) or enrollment (controls) (phv00169280.v2.p1)
Demographics (2)
- Age - Subject's age at ICH (cases) or enrollment (controls) (phv00169274.v2.p1)
- Sex - Subject's sex (phv00169275.v2.p1)
Disease Events (3)
- Diabetes - History of diabetes mellitus (phv00169299.v2.p1)
- Hyperlipidemia - History of hypercholesterolemia (phv00169300.v2.p1)
- Hypertension - History of hypertension (phv00169298.v2.p1)
Medications (10)
- Aspirin - Whether subject was taking aspirin at index (cases) or enrollment (controls) (phv00169286.v2.p1)
- Clopidogrel - Whether subject was taking clopidogrel at index (cases) or enrollment (controls) (phv00169290.v2.p1)
- Heparin - Whether subject was taking heparin at index (cases) or enrollment (controls) (phv00169283.v2.p1)
- INR - International Normalized Ratio lab value at admission (cases) or enrollment (controls) (phv00169279.v2.p1)
- OtherAnticoagulant - Whether subject was taking another or unknown anticoagulant at index (cases) or enrollment (controls) (phv00169285.v2.p1)
- OtherAntiplatelet - Whether subject was taking another or unknown antiplatelet at index (cases) or enrollment (controls) (phv00169296.v2.p1)
- Prasugrel - Whether subject was taking prasugrel at index (cases) or enrollment (controls) (phv00169294.v2.p1)
- PT - Prothrombin Time lab value at admission (cases) or enrollment (controls) (phv00169278.v2.p1)
- Ticlodipine - Whether subject was taking ticlodipine at index (cases) or enrollment (controls) (phv00169292.v2.p1)
- Warfarin - Whether subject was taking warfarin at index (cases) or enrollment (controls) (phv00169281.v2.p1)
Race and Ethnicity (2)
- Ethnicity - Subject's ethnicity (phv00169277.v2.p1)
- Race - Subject's race (phv00169276.v2.p1)
Substance Use (1)
- CurrentSmoking - Smoking status at index (cases) or enrollment (controls) (phv00169301.v2.p1)
Other (29)
- Analyte Type - Analyte Type (phv00388900.v1.p1)
- AspirinDose - Daily dose of aspirin (phv00169287.v2.p1)
- Baseline_ICH_Volume - Baselinbe ICH Volume (phv00388896.v1.p1)
- Body Site - Body Site (phv00388899.v1.p1)
- Case - Case or Control Status (phv00388895.v1.p1)
- ClopidogrelDose - Daily dose of clopidogrel (phv00169291.v2.p1)
- Cohort - What Cohort the subject is assoicated with (phv00388897.v1.p1)
- CONSENT - Subject consent status (phv00169259.v2.p1)
- Country - Subject's country of residence (phv00169272.v2.p1)
- EventYear - Year of ICH (cases) or enrollment (controls) (phv00169302.v2.p1)
- HeparinDose - Daily dose of heparin (phv00169284.v2.p1)
- Hospital - Hospital or University where subject was consented (phv00388894.v1.p1)
- ICHLctn - Location of hemorrhage in brain (phv00169303.v2.p1)
- ICHNumber - Number of hemorrhages (phv00169304.v2.p1)
- Is Tumor - Is the Sample from a Tumor (phv00388901.v1.p1)
- OtherAntiplateletDose - Daily dose of antiplatelet (phv00169297.v2.p1)
- PrasugrelDose - Daily dose of prasugrel (phv00169295.v2.p1)
- SAMPID - Sample ID (phv00388898.v1.p1)
- SAMPID - Sample ID (phv00169266.v2.p1)
- SOURCE_SUBJID - Subject ID used in the Source Repository (phv00169261.v2.p1)
- Streptokinase - Whether subject was taking streptokinase at index (cases) or enrollment (controls) (phv00169288.v2.p1)
- StreptokinaseDose - Daily dose of streptokinase (phv00169289.v2.p1)
- SUBJ_SOURCE - Name of third party repository where the sample has been obtained (phv00169260.v2.p1)
- SUBJID - De-identified subject ID (phv00169271.v2.p1)
- SUBJID - Subject ID (phv00169258.v2.p1)
- SUBJID - Subject ID (phv00169265.v2.p1)
- TiclodipineDose - Daily dose of ticlodipine (phv00169293.v2.p1)
- WarfarinDose - Weekly dose of warfarin medication (phv00169282.v2.p1)
- YearOfBirth - Subject's year of birth (phv00169273.v2.p1)